Clinical Trial Update: Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a digital diet and exercise program to reduce liver fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: St. George's Hospital, London | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease | Phase 4 | Status: NOT_YET_RECRUITING